Strategy explains OSPRI’s R&D direction

Date 31 October 2018

OSPRI makes a substantial investment in the Research and Development that informs the design of the TBfree programme. Now a three-year strategy document sets the direction for R&D projects and activities until 2021.

Working with key research partners such as Manaaki Whenua Landcare Research, AgResearch and New Zealand universities, OSPRI relies on a solid R&D network to inform the design of its disease management and pest/carrier species (vectors) control programme.

A substantial research budget of $2 million to $2.5 million supports scientific investigation into the science that underpins the programmes.

OSPRI is particularly interested in the relationship between pest/carrier species (vectors) and disease transmission. Ongoing research is directed at the development and implementation of new tools and processes for vector control, and for understanding the ecology of wildlife vectors and TB.

Research in key areas such as disease surveillance, livestock testing and disease diagnostics, alongside wildlife management, population density surveillance and population control, has contributed to TB control and eradication programme.

The efficacy of the 1080 and its use for to control the spread of disease remains controversial in some areas of society. There is active field research underway to manage, mitigate and resolve impacts on non-target species, such as deer and kea.

Alongside this, research continues into wildlife control and management alternatives to 1080.

Further challenges are emerging in related livestock disease diagnostics and testing, and movement diagnostics for animal health surveillance, and research is increasingly shifting from fundamental to applied. This pulls the focus onto understanding the important role of post-mortem surveillance in disease detection and management.

The company’s research priorities in support of the TB eradication goals are outlined in the document RESEARCH AND DEVELOPMENT STRATEGY TO 2021, available at

Research and Development Strategy to 2021 450x600

subscribe to ospri news